[1]
Vlachopanos G, Schizas D, Hasemaki N, Georgalis A. Pathophysiology of contrast-induced acute kidney injury (CIAKI). Curr Pharm Des 2019; 25(44): 4642-7.
[2]
Vergadis C, Festas F, Spathi E, Pappas P, Spiliopoulos S. Methods for reducing contrast use and avoiding acute kidney injury during endovascular procedures. Curr Pharm Des 2019; 25(44): 4648-55.
[3]
Patelis N, Doulaptsis M, Kykalos S, Spartalis E, Maskanakis A, Georgopoulos S. Physiology of intraluminal administration of Carbon Dioxide as a contrast medium. Curr Pharm Des 2019; 25(44): 4656-61.
[4]
Bisdas T, Koutsias S. Carbon dioxide as standard of care for zero contrast interventions: when, why and how? Curr Pharm Des 2019; 25(44): 4662-6.
[5]
Bates KM, Ghanem H, Hague J, Matheiken SJ. Standardisation of technique and volume of iodinated contrast administration during infrainguinal angioplasty. Curr Pharm Des 2019; 25(44): 4667-74.
[6]
Nana P, Kouvelos G, Brotis A, Spanos K, Giannoukas A, Matsagkas M. The effect of endovascular aneurysm repair on renal function in patients treated for abdominal aortic aneurysm. Curr Pharm Des 2019; 25(44): 4675-85.